Paradigm Biopharmaceuticals Financial Overview
Paradigm Biopharmaceuticals's market cap is currently AU$145.70M. The company's EPS TTM is AU$-0.033; its P/E ratio is ―; Paradigm Biopharmaceuticals is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
